REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

I G Pharma Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: I G Pharma Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

I G Pharma Limited is an unlisted company, incorporated on 14/06/2005. It has its registered office in the State of Uttarakhand, India. Company's corporate identification number (CIN) is U24232UR2005PLC011213 and registration number is 011213. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
12.4 Km Meerut Road Roorkee Libberheri
Haridwar; Uttarakhand; Postal Code: 247667

Contact Details: Purchase the I G Pharma Limited report to view the information.

Basic Information
Total Employees:
Purchase the I G Pharma Limited report to view the information.
Outstanding Shares:
Purchase the I G Pharma Limited report to view the information.
Registered Capital:
Purchase the I G Pharma Limited report to view the information.
Incorporation Date:
June 14, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
56.34%
Purchase this report to view the information.
11.89%
Purchase this report to view the information.
0.1%
Company Performance
Financial values in the chart are available after I G Pharma Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.19%▲
Total operating revenue
0.19%▲
Operating profit (EBIT)
-16.44%▼
EBITDA
4.63%▲
Net Profit (Loss) for the Period
-16.18%▼
Total assets
-5.65%▼
Total equity
3.49%▲
Operating Profit Margin (ROS)
-0.19%▼
Net Profit Margin
-0.14%▼
Return on Equity (ROE)
-0.79%▼
Debt to Equity Ratio
-23.34%▼
Quick Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo